The Swiss heroin trials

BMJ

Volumn 317, Issue 7164, 1998, Pages 1011-

  Venning, G R ^a   Wodak, Alex ^b   Hall, Wayne ^c   Farrell, Michael ^d  

^a Pharmaceutical Research Services   (United Kingdom)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85007750232     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.317.7164.1011     Document Type: Letter

References (8)

1. Farrell M, Hall W The Swiss heroin trials: testing alternative approaches. BMJ 1998; 316: 639. (28 February.)
2. In: Uchtenhagen A, Gutzwiller F, Dobler-Mikola A, eds. Programme for a medical prescription of narcotics: final report of the research representatives. Summary of the synthesis report. Zurich: University of Zurich 1997.
3. Farrell M, Hall W The Swiss heroin trials: testing alternative approaches. BMJ 1998; 316: 639. (28 February.)
4. Hartnoll R, Mitcheson M, Battersby A, Brown G, Ellis M, Fleming P, et al Evaluation of heroin maintenance in controlled trial. Arch Gen Psychiatry 1980; 37: 877–884.
5. McCusker C, Davies M Prescribing drug of choice to illicit heroin users: the experience of a UK community drug team. J Subst Abuse Treatment 1996; 13: 521–531.
6. Hall W, Darke S Trends in opiate overdose deaths in Australia 1979-1995 Sydney: University of New South Wales 1997(NDARC technical report.)
7. Tyrell I The US prohibition experiment: myth, history and implications. Addiction 1997; 92: 1405–1409.
8. Farrell M, Strang J Confusion between the drug legalisation and drug prescribing debate. Aust Drug Alcohol Rev 1990; 9: 364–368.